|Systematic (IUPAC) name|
|Mol. mass||299.41 g/mol|
Proxorphan is an opioid analgesic and antitussive drug of the morphinan family that was never marketed. It acts as a κ-opioid receptor partial agonist and to a lesser extent as a μ-opioid receptor partial agonist.
- David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall.
- Leander JD (October 1983). "Further study of kappa opioids on increased urination". The Journal of Pharmacology and Experimental Therapeutics 227 (1): 35–41.
- Hayes AG, Birch PJ (August 1988). "Reversal by beta-funaltrexamine and 16-methyl cyprenorphine of the antinociceptive effects of opioid agonists in the mouse and guinea-pig". Neuropharmacology 27 (8): 813–6.
- Picker MJ, Dykstra LA (May 1989). "Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists". The Journal of Pharmacology and Experimental Therapeutics 249 (2): 557–66.
- Picker MJ, Craft RM, Negus SS, et al. (November 1992). "Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats". The Journal of Pharmacology and Experimental Therapeutics 263 (2): 668–81.